Picture ConsulTech GmbH GDPR-compliant E-Col Cloud Document Management 650x80px

Organisation › Details

Boehringer Ingelheim Pharmaceuticals Inc.

	Start	1997-02-01 existent
	Group	Boehringer Ingelheim (Group)
	Industry	pharmaceutical

	Street	900 Ridgebury Road P.O. Box 368
	City	06877-0368 Ridgefiled, CT
	Tel	+1-203-798-9988
		Address record changed: 2018-07-24

Basic data	Employees	n. a.


		Record changed: 2018-10-31

Picture EBD Group BIO-Europe 2020 Digital Event BEU2020 650x81

More documents for Boehringer Ingelheim (Group)

[1] Boehringer Ingelheim. (7/2/20). "Press Release: Boehringer Ingelheim Launches External Innovation Hub in China". Ingelheim....
[2] Boehringer Ingelheim. (6/8/20). "Press Release: New Consortium EUbOPEN Will Provide Tools to Unlock Disease Biology. 66 Million Euros to Generate Open-access Chemical Tools". Frankfurt & Ingelheim....
[3] Boehringer Ingelheim. (5/14/20). "Press Release: Boehringer Ingelheim Acquires Northern Biologics’ Preclinical Cancer Antibody Pipeline, Expanding Immuno-oncology Portfolio". Ingelheim & Toronto, ON....
[4] Boehringer Ingelheim. (3/30/20). "Press Release: Boehringer Ingelheim Opens Second Branch of Digital Lab BI X in Shanghai". Shanghai....
[5] Boehringer Ingelheim. (2/28/20). "Press Release: Boehringer Ingelheim Receives Positive CHMP Opinion for Nintedanib for the Treatment of Systemic Sclerosis-associated Interstitial Lung Disease". Ingelheim....
[6] Boehringer Ingelheim. (2/27/20). "Press Release: Boehringer Ingelheim Enters Discovery Stage Collaboration with Trutino Biosciences to Grow Its Cancer Immunology Portfolio with Novel Cytokine Platform". Ingelheim & San Diego, CA....
[7] Genedata AG. (2/26/20). "Press Release: Leading Biopharma Experts Drive R&D Innovation and Process Efficiency at the Genedata Partner Symposium". Basel....
[8] Boehringer Ingelheim. (2/18/20). "Press Release: Boehringer Ingelheim Launches Patient-Centric MyStudyWindow Powered by Carebox". Ingelheim & Raleigh, NC....
[9] Boehringer Ingelheim. (1/9/20). "Press Release: Boehringer Ingelheim Partners with Enleofen to Develop First-in-Class Anti-IL-11 Therapies for a Range of Fibrotic Diseases". Ingelheim & Singapore....
[10] PhoreMost Ltd.. (1/7/20). "Press Release: PhoreMost and Boehringer Ingelheim Enter Multi-project Drug Discovery Collaboration". Cambridge....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]